HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of effective neoadjuvant chemotherapy (MVEC) against right ureteral cancer involving bladder (cT4N1M0)].

Abstract
Poorly differentiated ureteral cancer has a poor prognosis, and tumor recurrence is frequent even after nephroureterectomy. We performed neoadjuvant chemotherapy to prevent postoperative recurrence. A 74-year-old man was diagnosed with ureteral cancer (3 cm) by magnetic resonance imaging (MRI). The clinical stage was T4N1M0. Histological examination by transurethral biopsy revealed an urothelial carcinoma, G3, pT1. After a month, the tumor size increased from 3.0 cm to 4.0 cm. With two cycles of neoadjuvant chemotherapy consisting of methotrexate, vinblastine, epirubicin and cisplatin (MVEC) partial remission (regression rate : 87%) was achieved, Following MVEC, right retroperitoneoscopy-assisted nephroureterectomy, total cystectomy, and ileal conduit were performed. Pathological stage was pT0. After two years, postoperative recurrence has not appeared.
AuthorsTakayuki Okada, Makoto Matsushita, Norihiko Kawamura, Takeshi Ujike, Mikio Nin, Masao Tsujihata
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 60 Issue 4 Pg. 179-82 (Apr 2014) ISSN: 0018-1994 [Print] Japan
PMID24882230 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Epirubicin
  • Vinblastine
  • Cisplatin
  • Methotrexate
Topics
  • Aged
  • Antibiotics, Antineoplastic (administration & dosage)
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Cisplatin (administration & dosage)
  • Epirubicin (administration & dosage)
  • Humans
  • Male
  • Methotrexate (administration & dosage)
  • Neoadjuvant Therapy
  • Treatment Outcome
  • Ureteral Neoplasms (pathology, therapy)
  • Urinary Bladder Neoplasms (pathology, therapy)
  • Vinblastine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: